Search Results
Optimizing conditioning regimens in patients with AML undergoing alloSCT
Optimization of Conditioning Regimen in Acute Leukemia - C. SCHMID
Reduced intensity vs myeloablative conditioning regimens in patients with AML and MDS
TBF as allo-HSCT conditioning regimen for myelofibrosis patients
Reduced-intensity conditioning regimens for adults with ALL: UKALL14 & ALL-RIC
FLAMSA-reduced intensity vs myeloablative conditioning for R/R AML with disease at transplantation
It’s All in the Timing
Managing GvHD in patients undergoing SCT
Improving transplantation outcomes in patients with active AML: current approaches & future outlooks
Should patients with AML who are MRD-positive proceed to allogeneic stem cell transplantation?
Total body irradiation vs. chemotherapy-based myeloablative conditioning for ASCT
Impact of conditioning intensity of allo-SCT for AML with molecular residual disease
